NYSE:NUS

Stock Analysis Report

Executive Summary

Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide.


Snowflake Analysis

6 star dividend payer and undervalued.


Similar Companies

Share Price & News

How has Nu Skin Enterprises's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: NUS's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-2.0%

NUS

-1.4%

US Personal Products

0.06%

US Market


1 Year Return

-53.4%

NUS

17.0%

US Personal Products

19.3%

US Market

Return vs Industry: NUS underperformed the US Personal Products industry which returned 17% over the past year.

Return vs Market: NUS underperformed the US Market which returned 19.3% over the past year.


Shareholder returns

NUSIndustryMarket
7 Day-2.0%-1.4%0.06%
30 Day-20.9%-0.4%1.7%
90 Day-21.6%7.2%9.0%
1 Year-52.2%-53.4%18.8%17.0%21.8%19.3%
3 Year-35.6%-40.0%68.3%60.3%49.5%39.9%
5 Year-36.8%-44.9%67.2%49.9%73.1%54.1%

Price Volatility Vs. Market

How volatile is Nu Skin Enterprises's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Nu Skin Enterprises undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: NUS ($29.79) is trading below our estimate of fair value ($89.19)

Significantly Below Fair Value: NUS is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: NUS is good value based on its PE Ratio (9.5x) compared to the Personal Products industry average (16.3x).

PE vs Market: NUS is good value based on its PE Ratio (9.5x) compared to the US market (18.5x).


Price to Earnings Growth Ratio

PEG Ratio: NUS's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: NUS is good value based on its PB Ratio (1.9x) compared to the US Personal Products industry average (1.9x).


Next Steps

Future Growth

How is Nu Skin Enterprises forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

-6.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: NUS's earnings are forecast to decline over the next 3 years (-6.7% per year).

Earnings vs Market: NUS's earnings are forecast to decline over the next 3 years (-6.7% per year).

High Growth Earnings: NUS's earnings are forecast to decline over the next 3 years.

Revenue vs Market: NUS's revenue (0.4% per year) is forecast to grow slower than the US market (7.6% per year).

High Growth Revenue: NUS's revenue (0.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: NUS's Return on Equity is forecast to be low in 3 years time (16.3%).


Next Steps

Past Performance

How has Nu Skin Enterprises performed over the past 5 years?

-3.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: NUS has high quality earnings.

Growing Profit Margin: NUS's current net profit margins (7.2%) are higher than last year (4.5%).


Past Earnings Growth Analysis

Earnings Trend: NUS's earnings have declined by -3.5% per year over the past 5 years.

Accelerating Growth: NUS's earnings growth over the past year (42.4%) exceeds its 5-year average (-3.5% per year).

Earnings vs Industry: NUS earnings growth over the past year (42.4%) exceeded the Personal Products industry 21.4%.


Return on Equity

High ROE: NUS's Return on Equity (19.8%) is considered low.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Nu Skin Enterprises's financial position?


Financial Position Analysis

Short Term Liabilities: NUS's short term assets ($740.2M) exceed its short term liabilities ($356.8M).

Long Term Liabilities: NUS's short term assets ($740.2M) exceed its long term liabilities ($537.0M).


Debt to Equity History and Analysis

Debt Level: NUS's debt to equity ratio (41.4%) is considered high.

Reducing Debt: NUS's debt to equity ratio has increased from 26.3% to 41.4% over the past 5 years.

Debt Coverage: NUS's debt is well covered by operating cash flow (49.2%).

Interest Coverage: NUS's interest payments on its debt are well covered by EBIT (13.9x coverage).


Balance Sheet

Inventory Level: NUS has a high level of physical assets or inventory.

Debt Coverage by Assets: NUS's debt is covered by short term assets (assets are 2x debt).


Next Steps

Dividend

What is Nu Skin Enterprises's current dividend yield, its reliability and sustainability?

5.03%

Current Dividend Yield


Upcoming Dividend Payment

Purchase Nu Skin Enterprises before the 'Buy Limit' to receive their next dividend payment.


Dividend Yield vs Market

company5.0%marketbottom25%1.4%markettop25%3.7%industryaverage1.4%forecastin3Years5.2%

Current dividend yield vs market & industry

Notable Dividend: NUS's dividend (5.04%) is higher than the bottom 25% of dividend payers in the US market (1.44%).

High Dividend: NUS's dividend (5.04%) is in the top 25% of dividend payers in the US market (3.71%)


Stability and Growth of Payments

Stable Dividend: NUS's dividends per share have been stable in the past 10 years.

Growing Dividend: NUS's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (47.3%), NUS's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: NUS's dividends in 3 years are forecast to be covered by earnings (60.6% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.9yrs

Average management tenure


CEO

Ritch Wood (53yo)

2.9yrs

Tenure

US$6,065,610

Compensation

Mr. Ritch N. Wood has been the Chief Executive Officer of Nu Skin Enterprises, Inc. since March 7, 2017. Mr. Wood served as the Chief Financial Officer at Nu Skin Enterprises Inc. from November 2002 to Mar ...


CEO Compensation Analysis

Compensation vs Market: Ritch's total compensation ($USD6.07M) is above average for companies of similar size in the US market ($USD3.81M).

Compensation vs Earnings: Ritch's compensation has increased by more than 20% in the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Steven Lund
Executive Chairman of the Board7.8yrsUS$1.26m0.45% $7.5m
Ritch Wood
CEO & Director2.9yrsUS$6.07m0.26% $4.3m
Ryan Napierski
President2.9yrsUS$3.47m0.13% $2.2m
Mark Lawrence
Executive VP & CFO2.9yrsUS$2.07m0.072% $1.2m
Joseph Chang
Executive VP of Product Development & Chief Scientific Officer14yrsUS$2.33m0.22% $3.6m
D. Dorny
Executive VP17.1yrsUS$1.94m0.066% $1.1m
Blake Roney
36.1yrsUS$621.69kno data
Sandra Tillotson
24.1yrsUS$1.06mno data
James Thomas
Chief Accounting Officer0.5yrsno data0.0059% $98.3k
Vince Perfetti
Chief Transformation Officer & Senior VP of Technology0.8yrsno datano data

2.9yrs

Average Tenure

55yo

Average Age

Experienced Management: NUS's management team is considered experienced (2.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Steven Lund
Executive Chairman of the Board7.8yrsUS$1.26m0.45% $7.5m
Ritch Wood
CEO & Director2.9yrsUS$6.07m0.26% $4.3m
Edwina Woodbury
Independent Director4.7yrsUS$298.44k0.010% $164.6k
Andrew Lipman
Independent Director20.8yrsUS$298.94k0.12% $2.1m
Daniel Campbell
Lead Independent Director0yrsUS$300.44k0.13% $2.2m
Lars Bohlin
Member of Anti-Aging Scientific Advisory Board0yrsno datano data
Thomas Pisano
Independent Director11.7yrsUS$298.44k0.085% $1.4m
Zoe Draelos
Member of the Anti-Aging Scientific Advisory Board10.1yrsno datano data
Tomas Prolla
Member of Anti-aging Scientific Advisory Board10.3yrsno datano data
Zheqing Shen
Independent Director3.6yrsUS$254.94k0.0099% $163.8k

8.9yrs

Average Tenure

66yo

Average Age

Experienced Board: NUS's board of directors are considered experienced (8.9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Nu Skin Enterprises, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Nu Skin Enterprises, Inc.
  • Ticker: NUS
  • Exchange: NYSE
  • Founded: 1984
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: US$1.655b
  • Shares outstanding: 55.55m
  • Website: https://www.nuskin.com

Number of Employees


Location

  • Nu Skin Enterprises, Inc.
  • 75 West Center Street
  • Provo
  • Utah
  • 84601
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NUSNYSE (New York Stock Exchange)YesClass A Common StockUSUSDNov 1996
NUSDB (Deutsche Boerse AG)YesClass A Common StockDEEURNov 1996
NUSSWX (SIX Swiss Exchange)YesClass A Common StockCHCHFNov 1996

Biography

Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/02/22 00:58
End of Day Share Price2020/02/21 00:00
Earnings2019/12/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.